The Revolution MD offering is now closed and is no longer accepting investments.

Revolution MD

Reinventing Medication Delivery

Revolution MD

Reinventing Medication Delivery

Knoxville, TN
Biotechnology
Health Tech
Revolution MD has developed a solution to the opioid epidemic. Our patented Smart Inhaler combines biometric authentication with abuse deterrents in a proprietary blockchain network, for a real solution to prevent overdose and properly taper off medication as prescribed by physicians. Designed alongside healthcare providers and supported by a team of pharmaceutical and regulatory experts, we believe our portable device will make the opioid crisis a thing of the past, finally providing a solution to a problem that affects millions of Americans.

$58,210

raised
81
Investors
$26.7M
Valuation
$2.00
Price per Share
$250.00
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
0
Days Left

$58,210

raised
81
Investors
$26.7M
Valuation
$2.00
Price per Share
$250.00
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
0
Days Left
This offering ended on July 29, 2022 and is no longer accepting investments.

Reasons to Invest

Opportunity to Invest in a Growing Biotech Market | The global biotechnology market stood at USD $627.63 Billion in 2020 and is expected to grow at a CAGR of 8.57% through 2026, while the global market for opioids was estimated at USD $25.4 Billion in 2020 and projected to reach US$31.9 Billion by 2027***
Revolution MD is supported by a world-class team of experts in pharmaceutical, regulatory, healthcare, cyber security, and finance industries, including Igor Gonda Pharma CEO, who successfully developed an opioid inhaler and navigated clinical trials.
Technology is Proven: 11 clinical trials have demonstrated the efficacy of inhaled opioids with fewer side effects

*Information provided by the Center for Disease Control and Prevention (source)

***Market statistics provided by Research and Markets (sourcesource)


*Images above are computer-generated renderings of the INHALE device. Product is currently under development.


The Problem



(source / source / source / source / source)

The Solution



*Images above are computer-generated renderings of the INHALE device. Product is currently under development.


The Market



(source / source / source / source)


Our Business Model



*Images above are computer-generated renderings of the INHALE device. Product is currently under development.


*Images above are computer-generated renderings of the INHALE device. Product is currently under development.


Why Invest



*Images above are computer-generated renderings of the INHALE device. Product is currently under development.


Replace
Drop image
(or click)

Loading image

In the Press

Teknovation

Revolution MD uses blockchain technology, IoT to dispense opioids more safely

Chicago News

REVOLUTION MD EXECUTES LETTER OF INTENT WITH FLAGSHIP CAPITAL FOR MULTI-MILLION DOLLAR INVESTMENT

Offering Summary


Company

:

Revolution MD, Inc

Corporate Address

:

5600 Crooked Pine Lane, Knoxville, TN 37921

Offering Minimum

:

$10,000.00

Offering Maximum

:

$1,070,000.00

Minimum Investment Amount

(per investor)

:

$250.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

5,000

Maximum Number of Shares Offered

:

535,000

Price per Share

:

$2.00

Pre-Money Valuation

:

$26,712,500.00











*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

Investment Incentives and Bonuses

Time-Based

Friends and Family Early Birds

Invest within the first 72 hours and receive 20% Bonus Shares.

Super Early Bird Bonus

Invest within the first week and receive 15% Bonus Shares.

Early Bird Bonus

Invest within the two weeks and receive 10% Bonus Shares.

Amount-Based

$1,000+ | Tier 1

Invest $1,000+ and receive 5% Bonus Shares.

$2,000+ | Tier 2

Invest $2,000+ and receive 10% Bonus Shares.

$5,000+ | Tier 3

Invest $5,000+ and receive 15% Bonus Shares.

$10,000+ | Tier 4

Invest $10,000+ and receive 20% Bonus Shares.

*All perks occur when the offering is completed.

The 10% StartEngine Owners' Bonus

Revolution MD will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $2.00 / share, you will receive 110 Common Stock, meaning you'll own 110 shares for $200. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Any expense labeled “Travel and Entertainment”. Salary payments made to one’s self, a friend or relative.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$14,324.00 USD
$5,017.00 USD
Cash And Cash Equivalents
$12,260.00 USD
$3,693.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$2,552.00 USD
$0.00 USD
Long Term Debt
$10,210.00 USD
$0.00 USD
Revenues And Sales
$0.00 USD
$0.00 USD
Costs Of Goods Sold
$0.00 USD
$0.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$89,253.00 USD
-$101,611.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Notice of Material Change in Offering

3 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the Revolution MD offering. Here's an excerpt describing the specifics of the change:


Issuer is extending campaign end date.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Kentucky Shatters its Fatal Overdose Record; Fentanyl Blamed

4 months ago

Knoxville June 14, 2022 - A new state report says fatal drug overdoses rose nearly 15% in Kentucky last year. The report says the increased use of fentanyl was a common contributor to the record death toll. Fentanyl is a powerful synthetic opioid that was identified in nearly 73% of 2021 overdose deaths.


The report says 2,250 Kentuckians died from drug overdoses in 2021, with the scourge plaguing rural counties and large cities alike. It’s the first time the state surpassed 2,000 drug overdose deaths in a year. The state’s rising death count mirrored the nation’s escalating overdose epidemic.

 

Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

 

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD is developing a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity in this ground breaking technology visit: https://www.startengine.com/revolution-md.

Inhalers Have Been Around Since the 1950’s

4 months ago

It wasn’t until the scientific and technological advancement of the English industrial revolution that the first inhaler was invented. New manufacturing capacities spurred the creation of nebulizers, dry-powder inhalers, and ceramic pot inhalers. The early 20th century also saw the commercialization of asthma cigarettes, ranging in ingredients from stramonium to tea leaves.

The major breakthrough came in the 1950s, when the metered dose inhaler (MDI) was invented. The first device to effectively deliver medicine to the lungs, the MDI set the stage for asthma technology to come, including breath-actuated MDIs, spacer devices, and dosage counters.

Revolution Md is developing a state-of-the-art inhaler that safe and effective in providing the pain relief patients need while minimizing the chances of addiction. 

Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our ground breaking smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

 

Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our ground breaking smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate. The long-term solution to the opioid problem requires an understanding of the massive costs when addictions are not successfully treated

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity visit: https://www.startengine.com/revolution-md

Opioids Cost Criminal Justice System $8 Billion Annually

4 months ago

Update Financial and Criminal Burden of the Opioid Crisis


KNOXVILLE, June 3, 2022 –The annual cost from the opioid crisis leapt nearly 600%. The cost to the criminal justice system was estimated at $8 Billion of which $270 million is borne by crime laboratories. However, laboratory budgets have not grown at a rate capable of meeting this increased demand for forensic science services. The hidden costs of the opioid crisis borne by the forensic crime laboratories comes as funds are diverted in the laboratory to meet the increased demands for services in drug chemistry and toxicology. Dramatic increases in turnaround times across other areas of investigation continue to grow as the crisis accelerates.

 

For more information: https://www.sciencedirect.com/science/article/pii/S2589871X19301470 

 

Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our ground breaking smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rateThe long-term solution to the opioid problem requires an understanding of the massive costs when addictions are not successfully treated

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity in this ground breaking technology visit: https://www.startengine.com/revolution-md.

THE COLD HARD TRUTH ABOUT OPIOIDS AND TEENAGERS

5 months ago

Over thirty percent of patients prescribed opioids for chronic pain misuse them

What makes opioid medications effective for treating pain can also make them dangerous.

At lower doses, opioids may make you feel sleepy, but higher doses can slow your breathing and heart rate, which can lead to death. And the feelings of pleasure that result from taking an opioid can make you want to continue experiencing those feelings, which may lead to addiction. Teenagers are especially at risk for opioid addiction. Prescription pain medications are especially dangerous for teenagers because their brains are still developing.


  • Nearly 700,000 teenagers misused opioid pain relievers in 2021.
  • Two out of three drug overdose deaths in 2021 involved an opioid. 
  • 2 out of 3 teens abusing prescription pain meds say they get them from family or friends.
  • Some teens hand out or sell extra pills of their own, or pills they’ve gotten or stolen from friends or family members.


Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our groundbreaking smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

 

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity in this ground breaking technology visit: https://www.startengine.com/revolution-md.

Women Hit Hardest by Opioid Crisis!

5 months ago

Women are experiencing increases of use and overdose from opioids at a faster rate than men. 

 

The national opioid epidemic, generally recognized as the greatest public health crisis since the dawn of the HIV/AIDS virus, is indisputably hardest on women. Natural and synthetic opioids increasingly are being used by women. These substances range from illegal drugs like heroin, to legally available pain relievers such as oxycodone and Fentanyl, a powerful analgesic similar to morphine but 50 to 100 times more potent.

 

The brain's opioid receptors respond differently to opioids in men and women. After taking an opioid, the onset of pain relief is typically slower in women than men. This may lead women to take more opioids than prescribed in an attempt to obtain pain relief. This can also lead to women developing an opioid addiction more rapidly than men, even when using lower doses for shorter time periods.

Women are experiencing increases of use and overdose from opioids at a faster rate than men.  And if you slice the demographic pie even more narrowly, the picture doesn't look a lot better. The opioid use disorder crisis affects women across all age groups, all racial groups, all ethnicities, all geographic quarters of America and all socioeconomic status levels."   

- Brian LeClair, HRSA Principal Deputy Administrator

https://www.hrsa.gov/enews/past-issues/2019/february-21/women-hit-hardest-by-opioid-crisis.

 

Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our ground breaking smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

 

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity in this ground breaking technology visit: https://www.startengine.com/revolution-md.

Opioid Use — Even Short Term — Can Lead to Addiction and, Too Often, Overdose

5 months ago

Anyone who takes opioids is at risk of developing addiction. Legal or illegal, stolen and shared, these drugs are responsible for the majority of overdose deaths in the U.S. today.

Opioids are highly addictive, in large part because they activate powerful reward centers in your brain. Opioids trigger the release of endorphins, your brain's feel-good neurotransmitters. Endorphins muffle your perception of pain and boost feelings of pleasure, creating a temporary but powerful sense of well-being. When an opioid dose wears off, you may find yourself wanting those good feelings back, as soon as possible. 

When you take opioids repeatedly over time, your body slows its production of endorphins. The same dose of opioids stops triggering such a strong flood of good feelings. This is called tolerance. One reason opioid addiction is so common is that people who develop tolerance may feel driven to increase their doses so they can keep feeling good.

Because doctors today are acutely aware of opioid risks, it's often difficult to get your doctor to increase your dose, or even renew your prescription. Opioid users who need an increased supply turn to illegally obtained opioids or heroin. Some illegally obtained drugs are laced with contaminants like Fentanyl, or much more powerful opioids. Because of the potency of fentanyl, this particular combination has been associated with a significant number of deaths in those using heroin.

Quitting these drugs abruptly can cause severe side effects, including pain worse than it was before you started taking opioids. Revolution MD’s inhale device can help you taper off opioids slowly and safely.

Opioid Video https://www.youtube.com/watch?v=YcENrBVXPsY.

https://www.mayoclinic.org/diseases-conditions/prescription-drug-abuse/in-depth/how-opioid-addiction-occurs/art-20360372.

Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our ground breaking smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

 

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

Child Deaths from Opioids Nearly Tripled in Recent Years, Says Yale Study

5 months ago

Ninety-one Americans die every day from an opioid overdose.

KNOXVILLE, May 18, 2022 – Prescription and illicit opioids combined have killed more than 300,000 Americans since 2000. This catastrophe of opioid addiction and deaths has fueled a heartbreaking increase of children in crisis.

From the earliest days of pregnancy children whose parents abuse opioids are at high risk. In addition to prenatal drug exposure, parents distracted by drugs and without help may be unable to provide children necessary care to grow and thrive. Children and teens are also susceptible to accidental opioid exposure and misuse. Whether children are born suffering from drug exposure, their parents’ addiction struggle leads to toxic stress or involvement with the child welfare system, or they use or are accidentally exposed to drugs themselves, opioid addiction has a devastating impact.

Children in households where parents struggle with substance abuse are more likely to experience long-term effects of neglect or abuse than other children. This early trauma exposure makes them more likely to suffer later mental health disorders including substance abuse and post-traumatic stress disorder. Some physicians report an increase in child and teen suicides they link to the opioid crisis.

https://news.yale.edu/2018/12/28/child-deaths-opioids-nearly-tripled-recent-years-says-yale-study.

https://www.childrensdefense.org/child-watch-columns/health/2017/children-and-the-opioid-crisis/.

Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our groundbreaking smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

 

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity in this ground breaking technology visit: https://www.startengine.com/revolution-md.

The Cost of the Opioid Crisis has Ballooned to Over 1 Trillion Dollars

5 months ago

KNOXVILLE, May 13, 2022 – The opioid financial toll in America for patients who experienced an opioid overdose accounted for $1.94 billion in annual hospital costs.  Drug-related crime, theft, and criminal justice costs have ballooned to over $14.8 billion in criminal justice costs. There has been $92 billion lost in work productivity. The losses stem from premature death due to overdose, “productive hours” lost to OUD, and opioid-related incarceration.

 

The costs of the opioid crisis are borne by individuals in the form of lost wages; the private sector in lost productivity and health care costs; and federal, state and local governments in lost tax revenue and additional spending on health care, social services, education and criminal justice.

https://www.pewtrusts.org/en/research-and-analysis/data-visualizations/2021/the-high-price-of-the-opioid-crisis-2021.

Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our ground breaking smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

 

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity in this ground breaking technology visit: https://www.startengine.com/revolution-md.

Revolution MD | Fentanyl Deaths on the Rise as Opioid Addiction Continues to Skyrocket

5 months ago

FDA “Fentanyl is 80-100 times stronger than morphine.”

KNOXVILLE, May 13, 2022 – Fentanyl is a synthetic opioid typically used to treat patients with chronic severe pain or severe pain following surgery that is 80-100 times stronger than morphine. Under the supervision of a licensed medical professional, fentanyl has a legitimate medical use.  

Illicit fentanyl, primarily manufactured in foreign clandestine labs and smuggled into the United States through Mexico, is being distributed across the country and sold on the illegal drug market.  Fentanyl is being pressed into pills made to look like legitimate prescription opioids.  Because there is no official oversight or quality control, these counterfeit opioid pills often contain lethal doses of fentanyl, with none of the promised drug.

Here are some startling facts:

  • 42% of pills tested for fentanyl contained at least 2 mg of fentanyl, considered a potentially lethal dose.
  • Drug trafficking organizations typically distribute fentanyl by the kilogram.  One kilogram of fentanyl has the potential to kill 500,000 people.
  • Overdose deaths involving opioids rose 38.1 percent.
  • Overdose deaths involving synthetic opioids (primarily illicitly manufactured fentanyl) rose 55.6 percent and appear to be the primary driver of the increase in total drug overdose deaths. 
  •  

For more information click here: https://www.dea.gov/resources/facts-about-fentanyl.

 

Revolution MD Inc. (“Revolution MD”). We at Revolution MD believe our ground breaking smart opioid device is one answer to help combat this epidemic of suffering as loss of lives affecting our communities. Revolution MD’s smart inhaler authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

 

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity in this ground breaking technology visit: https://www.startengine.com/revolution-md.

4 U.S. Companies Will Pay $26 Billion to Settle Claims That Fueled the Opioid Crisis.

5 months ago

Drug overdoses now kill more than 100,000 people in the U.S. every year, according to the CDCP.

KNOXVILLE, May 9, 2022 – Four of the largest U.S. corporations have agreed to pay roughly $26 billion to settle a tsunami of lawsuits linked to claims that their business practices helped fuel the deadly opioid crisis. Johnson & Johnson, the consumer products and health giant that manufactured generic opioid medications, will contribute $5 billion to the settlement.

Three massive drug wholesalers — AmerisourceBergen, Cardinal Health and McKesson — will pay a combined $21 billion. Most of the funds are earmarked for health care and drug treatment programs designed to ease the opioid crisis.   "The settlement will provide thousands of communities across the United States with up to approximately $19.5 billion over 18 years," the drug distributors said in their statement.

Initial payments will begin in May and will continue over the next two decades. Many Americans with opioid use disorder have shifted from taking prescription pain pills to street fentanyl, a synthetic opioid that is far more powerful and lethal.

https://www.npr.org/2022/02/25/1082901958/opioid-settlement-johnson-26-billion.

Revolution MD Inc. (“Revolution MD”), To help combat this epidemic affecting our communities, Revolution MD has introduced their ground breaking smart opioid inhaler the authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

 

 

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity in this ground breaking technology visit: https://www.startengine.com/revolution-md.

Revolution MD’s smart Inhaler Helps Combat the Negative Side Effects of Opioids

5 months ago

What makes opioid medications so dangerous and the risks when the medications are abused. Rev MD’s smart inhaler helps combat the negative side effects of opioids

MAYO CLINIC May 4, 2022 – When used as prescribed by your doctor, opioid medications safely help control acute pain, such as pain you experience after surgery. There are risks when the medications are used incorrectly. Opioids are a broad group of pain-relieving drugs that work by interacting with opioid receptors in your cells. Opioids can be made from the poppy plant — for example, morphine (Kadian, Ms Contin, others) — or synthesized in a laboratory — for example, fentanyl (Actiq, Duragesic, others).

When opioid medications travel through your blood and attach to opioid receptors in your brain cells, the cells release signals that muffle your perception of pain and boost your feelings of pleasure.

What makes opioid medications effective for treating pain can also make them dangerous.

At lower doses, opioids may make you feel sleepy, but higher doses can slow your breathing and heart rate, which can lead to death. And the feelings of pleasure that result from taking an opioid can make you want to continue experiencing those feelings, which may lead to addiction.

Revolution MD Inc. (“Revolution MD”), Revolution MD has introduced their ground breaking smart opioid inhaler the authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and is a Nevada corporation and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

For more information and an investment opportunity in this ground breaking technology visit: https://www.startengine.com/revolution-md.

Revolution MD offers Resources to Help People and Their Families Who are Struggling with Opioid Addiction

5 months ago

Knoxville TN, May 3, 2022. Revolution MD’s CEO Josh Kimmel understands all to clearly the struggles people have with opioid addiction as he was an addict himself.  It is that struggle that inspired him to start Revolution MD and launch their ground breaking inhale device to help alleviate opioid abuse and diversion.

Josh stated “My story is not unique. I was introduced to opioids when I had knee surgery. After surgery, I continued to use opioids recreationally because they gave me a powerful feeling of well-being, euphoria, and a host of other good feelings. I knew the warnings about addiction to the drug but I thought that would never affect me.”

Here are some resource options for support for you, your families or your friends who may be struggling with opioid abuse or addiction.

“We are excited about the introduction of our ground breaking smart opioid inhaler that authenticates the patient and releases a measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and reduce addiction," Josh said.


Disclaimer: 

These testimonials may not be representative of the experience of other customers and are no guarantee of future performance or success.

Revolution MD Engages Media Whisper Agency to focus on growth and development of social media communities.

5 months ago

Revolution MD is a biotech innovator focused on controlling how opioids are safely dispensed. Media Whisper develops of social media communities and brand strategies nationwide with some of the largest brands in the world including Live Nation, AMC Network, Radio City Music Hall and many others. 

 

KNOXVILLE, April 29,2022 - Revolution MD Inc. (“Revolution MD”), Revolution MD has hired Nashville based Media Whisper agency to help the company grow its digital reach and introduce their groundbreaking smart opioid inhaler the authenticates the patient and releases a pre-measured dose of fast-acting prescription opioid. The dosage amount and time sequence built into the device helps prevent abuse. It also allows a medical professional, as the patient’s prescription is coming to an end, to taper the dosage of the drug to reduce the effects of withdrawal and to diminish the addiction rate.

Revolution MD President Josh Kimmel stated “We are excited about Media Whisper joining our team. They understand how to access the digital communities as we are working to engage people that have been devastated by the Opioid crisis of addiction and loss of life”.

Media Whisper President Brandon Brown stated “I was absolutely blown away when I first learned about Revolution MD’s work to solve the opioid crisis. Their smart inhaler and the team behind its development are not only disruptive, but uniquely positioned to provide a much-needed solution to this epidemic, which has affected the lives of family members and loved ones extremely close to me. I knew in a heartbeat that this was a project we would wholeheartedly support, and we’re honored to be a part of such a worthy mission.”

Notice of Material Change in Offering

6 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the Revolution MD offering. Here's an excerpt describing the specifics of the change:


The campaign has extended their end date by 60 days and updated their financials to 2020/2021


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Revolution MD Executes Letter of Intent with Flagship Capital for Multi-Million Dollar Investment

6 months ago

Revolution MD Executes Letter of Intent with Flagship Capital for Multi-Million Dollar Investment

 

KNOXVILLE, April 7, 2022 – Revolution MD Inc. ("Revolution MD), a biotech innovator focused on controlling how opioids are safely dispensed, today announced the execution of a non-binding Letter of Intent with Flagship Capital Legacy Fund ("Flagship Capital").  Flagship Capital Legacy Fund is a social impact/ESG fund focused on 4 key areas. Waste to Energy, Ocean Cleanup, Opioid Crisis and Alternative solutions to helping small businesses recover from the Covid19 pandemic. 


Under terms of the above-mentioned Letter of Intent, dated April 7, 2022, Flagship Capital Legacy Fund intends to make an investment of $2M ($2,000,000) - $5M ($5,000,000.00) in exchange for an equity stake in Revolution MD.

 

Revolution MD President Mr. Josh Kimmel stated "This is a significant and timely investment that will allow us to add substantial value to the Company and its shareholders by achieving important milestones in our effort to address a critical component of the Opioid Crisis. 

Casey Pond Principal of Flagship Capital stated, “We have been thoroughly impressed with the unique and innovative approach to address a root cause of the Opioid Epidemic, in addition to the world class talent the Company has assembled. Revolution MD is a valuable addition to our portfolio.”   

About Revolution MD Inc.

Revolution MD is based Knoxville, TN and was incorporated in 2018. Revolution MD has developed a solution to address the root cause of the opioid epidemic, by controlling how opioids are dispensed. The Company is developing a patented Smart Inhaler controlled by a proprietary blockchain network that utilizes biometric authentication and physical abuse deterrents. The network provides real time connectivity and control of the device allowing interfaces with health care providers, enables remote activation and deactivation and the ability to taper patients off the medication. The data captured by the network is invaluable for various stakeholders including pharmaceutical companies, health care professionals, prescribing physicians, law enforcement and regulatory agencies.

 

About Flagship Capital Legacy Fund

Flagship Capital Legacy Fund is a social impact/ESG fund, with 4 key areas of focus: Waste to Energy, Ocean Cleanup, Opioid Crisis and Alternative solutions to helping small businesses recover from the Covid19 pandemic.

SOURCE Revolution MD Inc. 

For more information go to Rev-MD.com

It should be noted that letters of intent are non-binding contracts

Investments have increased over 110% in less than 2 weeks!

7 months ago

We are excited to announce that investments in our crowdfunding campaign have increased over 100% in the last 2 weeks and are gaining momentum. Reaching this milestone is a true testament to the incredible support we’ve received from emails, phone calls and messages on social media. We are humbled beyond belief. Thank you to our early investors, your support is very much appreciated! 

Please share this with others that have been affected by the opioid crisis and will support our effort to make opioids safer.

Stay tuned in the coming weeks as we share our progress as it develops.

 

Thank you from the entire Revolution MD Team




Revolution MD CEO Josh Kimmel's Addiction Story

9 months ago

My name is Josh and I am the CEO of Revolution MD. I started this company because I was an opioid addict!

When opioids are used as prescribed, they provide immediate pain relief and help millions of patients globally. But when they are abused, the physical and mental devastation to the patient and all those around them is heart breaking.

My story is not unique. I was introduced to opioids when I had knee surgery. After surgery, I continued to use opioids recreationally because they gave me a powerful feeling of well-being, euphoria, and a host of other good feelings. I knew the warnings about addiction to the drug but I thought that would never affect me. 

Over time, the number of opioids I needed daily kept getting larger to achieve the high I craved and I needed more money to fund my increasing addiction. My life became a vicious cycle of waking up and either taking opioids every hour or two until going to bed, or desperately trying to find more, feeling like I was going to die if I couldn’t. I no longer had goals or aspirations; I wasn’t thinking about my future or doing anything positive for myself or my family.

But getting clean from opioids is not that easy and I relapsed multiple times until I finally was able to stick with Methadone and began functioning without the desire of chasing a high every hour. 

After almost a year of sobriety, I started to experience an overwhelming feeling of spiritual awakening and was inspired to be alive and ready to take on the world again! I knew in that moment my passion was to find a way to curb the abuse and addiction from opioid addiction that is crippling patients and families all over the world

 So, I started Revolution MD. 

Our mission is to bring to market a smart inhaler designed to safely control the dispensing of opioids within prescribed limits, providing immediate pain relief while minimizing the risk of addiction. 

We launched our funding campaign to find likeminded investors who wanted to help us create a solution for this major problem that is rampant across the globe and the opportunity to invest from the ground floor up in a new technology that can revolutionize the way we dispense and control pharmaceuticals in the future.

We are excited about the future of Rev MD and encourage you to join us on our noble journey.


Josh Kimmel

President & Founder

Revolution MD Corp.


Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}